Comparative study analyzing survival and safety of bevacizumab/carboplatin/paclitaxel versus carboplatin/docetaxel in initial treatment of metastatic Her-2-negative breast cancer

Por Kader, Yasser Abdel, Spielmann, Marc, El-Nahas, Tamer, Sakr, Amr, Metwally, Hassan
Publicado em 2013

3D-conformal Accelerated Partial Breast Irradiation treatment planning: the value of surgical clips in the delineation of the lumpectomy cavity

Por Dzhugashvili, Maia, Tournay, Elodie, Pichenot, Charlotte, Dunant, Ariane, Pessoa, Eduardo, Khallel, Adel, Gouy, Sébastien, Uzan, Catherine, Garbay, Jean-Rémy, Rimareix, Françoise, Spielmann, Marc, Vielh, Philippe, Marsiglia, Hugo, Bourgier, Céline
Publicado em 2009

Efficacy of Trastuzumab in Routine Clinical Practice and After Progression for Metastatic Breast Cancer Patients: The Observational Hermine Study

Por Extra, Jean-Marc, Antoine, Eric C., Vincent-Salomon, Anne, Delozier, Thierry, Kerbrat, Pierre, Bethune-Volters, Anne, Guastalla, Jean-Paul, Spielmann, Marc, Mauriac, Louis, Misset, Jean-Louis, Serin, Daniel, Campone, Mario, Hebert, Christophe, Remblier, Céline, Bergougnoux, Loïc, Campana, Frank, Namer, Moïse
Publicado em 2010

Efficacy of Adjuvant Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Early Breast Cancer and Tumors ≤ 2 cm: A Meta-Analysis of the Randomized Trastu...

Por O'Sullivan, Ciara C., Bradbury, Ian, Campbell, Christine, Spielmann, Marc, Perez, Edith A., Joensuu, Heikki, Costantino, Joseph P., Delaloge, Suzette, Rastogi, Priya, Zardavas, Dimitrios, Ballman, Karla V., Holmes, Eileen, de Azambuja, Evandro, Piccart-Gebhart, Martine, Zujewski, Jo Anne, Gelber, Richard D.
Publicado no J Clin Oncol (2015)

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

Por Ladoire, Sylvain, Penault-Llorca, Frédérique, Senovilla, Laura, Dalban, Cécile, Enot, David, Locher, Clara, Prada, Nicole, Poirier-Colame, Vichnou, Chaba, Kariman, Arnould, Laurent, Ghiringhelli, François, Fumoleau, Pierre, Spielmann, Marc, Delaloge, Suzette, Poillot, Marie Laure, Arveux, Patrick, Goubar, Aicha, Andre, Fabrice, Zitvogel, Laurence, Kroemer, Guido
Publicado no Autophagy (2015)

Extended Benefit from Sequential Administration of Docetaxel after Standard Fluorouracil, Epirubicin, and Cyclophosphamide Regimen for Node-Positive Breast Cancer: The 8-Year Follo...

Por Coudert, Bruno, Asselain, Bernard, Campone, Mario, Spielmann, Marc, Machiels, Jean-Pascal, Pénault-Llorca, Frédérique, Serin, Daniel, Lévy, Christelle, Romieu, Gilles, Canon, Jean-Luc, Orfeuvre, Hubert, Piot, Gilles, Petit, Thierry, Jerusalem, Guy, Audhuy, Bruno, Veyret, Corinne, Beauduin, Marc, Eymard, Jean-Christophe, Martin, Anne-Laure, Roché, Henri
Publicado em 2012

Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review

Por Luporsi, Elisabeth, André, Fabrice, Spyratos, Frédérique, Martin, Pierre-Marie, Jacquemier, Jocelyne, Penault-Llorca, Frédérique, Tubiana-Mathieu, Nicole, Sigal-Zafrani, Brigitte, Arnould, Laurent, Gompel, Anne, Egele, Caroline, Poulet, Bruno, Clough, Krishna B., Crouet, Hubert, Fourquet, Alain, Lefranc, Jean-Pierre, Mathelin, Carole, Rouyer, Nicolas, Serin, Daniel, Spielmann, Marc, Haugh, Margaret, Chenard, Marie-Pierre, Brain, Etienne, de Cremoux, Patricia, Bellocq, Jean-Pierre
Publicado em 2011